BRADFORD SCHOLARS

    • Sign in
    View Item 
    •   Bradford Scholars
    • Life Sciences
    • Life Sciences Publications
    • View Item
    •   Bradford Scholars
    • Life Sciences
    • Life Sciences Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of Bradford ScholarsCommunitiesAuthorsTitlesSubjectsPublication DateThis CollectionAuthorsTitlesSubjectsPublication Date

    My Account

    Sign in

    HELP

    Bradford Scholars FAQsCopyright Fact SheetPolicies Fact SheetDeposit Terms and ConditionsDigital Preservation Policy

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Novel antibodies directed against the human erythropoietin receptor: creating a basis for clinical implementation

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    View/Open
    El-Tanani_British_Journal_of_Haematology.pdf (1.325Mb)
    Download
    Publication date
    2015
    Author
    Maxwell, P.
    Melendez-Rodriguez, F.
    Matchett, K.B.
    Aragones, J.
    Ben-Califa, N.
    Jackel, H.
    Hengst, L.
    Lindner, H.
    Bernardini, A.
    Brockmeier, U.
    Fandrey, J.
    Grunert, F.
    Oster, H.S.
    Mittelman, M.
    El-Tanani, Mohamed
    Thiersch, M.
    Schneider Gasser, E.M.
    Gassmann, M.
    Dangoor, D.
    Cuthbert, R.J.
    Irvine, A.
    Jordan, A.
    Lappin, T.R.
    Thompson, J.
    Neumann, D.
    Show allShow less
    Keyword
    Cancer anaemia; Recombinant erythropoietin; Erythropoietin receptor; Antibody; Risk assessment
    Rights
    © 2014 Wiley This is the peer reviewed version of the following article: Maxwell P, Melendez-Rodriguez F, Matchett KB et al. (2015) Novel antibodies directed against the human erythropoietin receptor: creating a basis for clinical implementation. British Journal of Haematology. 168: 429-442, which has been published in final form at http://dx.doi.org/10.1111/bjh.13133 . This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving.
    Peer-Reviewed
    Yes
    
    Metadata
    Show full item record
    Abstract
    Recombinant human erythropoietin (rHuEPO) is an effective treatment for anaemia but concerns that it causes disease progression in cancer patients by activation of EPO receptors (EPOR) in tumour tissue have been contro- versial and have restricted its clinical use. Initial clinical studies were flawed because they used polyclonal antibodies, later shown to lack specificity for EPOR. Moreover, multiple isoforms of EPOR caused by differential splicing have been reported in cancer cell lines at the mRNA level but investigations of these variants and their potential impact on tumour progression, have been hampered by lack of suitable antibodies. The EpoCan consortium seeks to promote improved pathological testing of EPOR, leading to safer clinical use of rHuEPO, by producing well characterized EPOR antibodies. Using novel genetic and traditional peptide immunization protocols, we have produced mouse and rat monoclonal antibodies, and show that sev- eral of these specifically recognize EPOR by Western blot, immunoprecipi- tation, immunofluorescence, flow cytometry and immunohistochemistry in cell lines and clinical material. Widespread availability of these antibodies should enable the research community to gain a better understanding of the role of EPOR in cancer, and eventually to distinguish patients who can be treated safely by rHuEPO from those at increased risk from treatment.
    URI
    http://hdl.handle.net/10454/8404
    Version
    Accepted Manuscript
    Citation
    Maxwell P, Melendez-Rodriguez F, Matchett KB et al. (2015) Novel antibodies directed against the human erythropoietin receptor: creating a basis for clinical implementation. British Journal of Haematology. 168: 429-442.
    Link to publisher’s version
    http://dx.doi.org/10.1111/bjh.13133
    Type
    Article
    Collections
    Life Sciences Publications

    entitlement

     
    DSpace software (copyright © 2002 - 2023)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.